C Partners Holding Gmb H Pfizer Inc Transaction History

C Partners Holding Gmb H

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 07, 2019	SELL	$38.47 - $43.86 $116,102 - $132,369	-3,018 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$34.47 - $41.81 $101,514 - $123,130	-2,945 Reduced 49.39%	3,018 $133,000
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $1,681 - $1,793	-51 Reduced 0.85%	5,963 $216,000
Q1 2018 May 15, 2018	SELL	$31.91 - $37.02 $46,939 - $54,456	-1,471 Reduced 19.65%	6,014 $213,000
Q4 2017 Feb 14, 2018	BUY	$33.26 - $35.29 $248,951 - $264,145	7,485	7,485 $271,000

3,253

3.72B

73.5M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of C Partners Holding Gmb H, based on Form 13F filings with the SEC.

Stay updated on C Partners Holding Gmb H with notifications on news.